{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:11:42Z","timestamp":1761988302320,"version":"3.44.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1378\/chest.10-0738","type":"journal-article","created":{"date-parts":[[2010,6,24]],"date-time":"2010-06-24T23:40:23Z","timestamp":1277422823000},"page":"486-490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Determining the Optimal Pneumococcal Vaccination Strategy for Adults"],"prefix":"10.1016","volume":"138","author":[{"given":"Mark L.","family":"Metersky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark T.","family":"Dransfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa A.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1378\/chest.10-0738_bib10","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","article-title":"Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine","volume":"294","author":"Lexau","year":"2005","journal-title":"JAMA"},{"issue":"3","key":"10.1378\/chest.10-0738_bib20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/MCP.0b013e3283287c3f","article-title":"Community-acquired pneumonia","volume":"15","author":"Carbonara","year":"2009","journal-title":"Curr Opin Pulm Med"},{"issue":"2","key":"10.1378\/chest.10-0738_bib30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1055\/s-0029-1202937","article-title":"Community-acquired pneumonia: the U.S. perspective","volume":"30","author":"Niederman","year":"2009","journal-title":"Semin Respir Crit Care Med"},{"issue":"10","key":"10.1378\/chest.10-0738_bib40","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1086\/592691","article-title":"Pneumococcal vaccination of elderly adults: new paradigms for protection","volume":"47","author":"Jackson","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"21","key":"10.1378\/chest.10-0738_bib50","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJM198611203152104","article-title":"Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study","volume":"315","author":"Simberkoff","year":"1986","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1378\/chest.10-0738_bib60","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1056\/NEJMoa022678","article-title":"Effectiveness of pneumococcal polysaccharide vaccine in older adults","volume":"348","author":"Jackson","year":"2003","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1378\/chest.10-0738_bib70","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2165\/00002512-200724100-00001","article-title":"Advances in pneumococcal vaccines: what are the advantages for the elderly?","volume":"24","author":"Vila-C\u00f3rcoles","year":"2007","journal-title":"Drugs Aging"},{"issue":"23\u201324","key":"10.1378\/chest.10-0738_bib80","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1016\/j.vaccine.2003.08.050","article-title":"The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials","volume":"22","author":"Conaty","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1378\/chest.10-0738_bib90","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1503\/cmaj.080734","article-title":"Efficacy of pneumococcal vaccination in adults: a meta-analysis","volume":"180","author":"Huss","year":"2009","journal-title":"CMAJ"},{"issue":"11\u201312","key":"10.1378\/chest.10-0738_bib100","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.vaccine.2004.01.029","article-title":"Review of pneumococcal conjugate vaccine in adults: implications on clinical development","volume":"22","author":"Abraham-Van Parijs","year":"2004","journal-title":"Vaccine"},{"issue":"9","key":"10.1378\/chest.10-0738_bib110","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1586\/14760584.7.9.1367","article-title":"Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era","volume":"7","author":"Dinleyici","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"8","key":"10.1378\/chest.10-0738_bib120","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1586\/erv.09.68","article-title":"Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine","volume":"8","author":"Dinleyici","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"10.1378\/chest.10-0738_bib130","first-page":"514","article-title":"Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides","volume":"10","author":"Wernette","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"issue":"2","key":"10.1378\/chest.10-0738_bib140","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1086\/520200","article-title":"Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity","volume":"29","author":"Romero-Steiner","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1378\/chest.10-0738_bib150","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/314845","article-title":"Correlation of opsonophagocytosis and passive protection assays using human anticapsular antibodies in an infant mouse model of bacteremia for Streptococcus pneumoniae","volume":"180","author":"Johnson","year":"1999","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1378\/chest.10-0738_bib160","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/cdli.4.4.415-422.1997","article-title":"Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells","volume":"4","author":"Romero-Steiner","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"issue":"11","key":"10.1378\/chest.10-0738_bib170","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.vaccine.2006.12.008","article-title":"ELISA IgG concentrations and opsonophagocytic activity following pneumococcal protein D conjugate vaccination and relationship to efficacy against acute otitis media","volume":"25","author":"Schuerman","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1378\/chest.10-0738_bib180","first-page":"1","article-title":"Surveillance of certain health behaviors and conditions among states and selected local areas\u2014Behavioral Risk Factor Surveillance System, United States, 2007","volume":"59","author":"Chowdhury","year":"2010","journal-title":"MMWR Surveill Summ"},{"issue":"24","key":"10.1378\/chest.10-0738_bib190","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1001\/jama.1977.03280250039019","article-title":"Protective efficacy of pneumococcal polysaccharide vaccines","volume":"238","author":"Smit","year":"1977","journal-title":"JAMA"},{"issue":"8026","key":"10.1378\/chest.10-0738_bib200","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/S0140-6736(77)92552-1","article-title":"Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community","volume":"1","author":"Riley","year":"1977","journal-title":"Lancet"},{"issue":"9100","key":"10.1378\/chest.10-0738_bib210","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0140-6736(97)07358-3","article-title":"Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people","volume":"351","author":"Ortqvist","year":"1998","journal-title":"Lancet"},{"key":"10.1378\/chest.10-0738_bib220","doi-asserted-by":"crossref","first-page":"c1004","DOI":"10.1136\/bmj.c1004","article-title":"Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial","volume":"340","author":"Maruyama","year":"2010","journal-title":"BMJ"},{"key":"10.1378\/chest.10-0738_bib230","doi-asserted-by":"crossref","first-page":"c1139","DOI":"10.1136\/bmj.c1139","article-title":"Pneumococcal polysaccharide vaccine in high risk adults","volume":"340","author":"Moberley","year":"2010","journal-title":"BMJ"},{"issue":"18","key":"10.1378\/chest.10-0738_bib240","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1001\/archinte.167.18.1938","article-title":"Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia","volume":"167","author":"Johnstone","year":"2007","journal-title":"Arch Intern Med"},{"issue":"21","key":"10.1378\/chest.10-0738_bib250","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJM199111213252101","article-title":"The protective efficacy of polyvalent pneumococcal polysaccharide vaccine","volume":"325","author":"Shapiro","year":"1991","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1378\/chest.10-0738_bib260","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000422.pub2","article-title":"Vaccines for preventing pneumococcal infection in adults","author":"Moberley","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1378\/chest.10-0738_bib270","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"issue":"18","key":"10.1378\/chest.10-0738_bib280","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1378\/chest.10-0738_bib290","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1016\/j.vaccine.2007.02.062","article-title":"Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide-protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine","volume":"25","author":"Jackson","year":"2007","journal-title":"Vaccine"},{"issue":"7","key":"10.1378\/chest.10-0738_bib300","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1086\/529142","article-title":"Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory","volume":"46","author":"de Roux","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1378\/chest.10-0738_bib310","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1164\/rccm.200903-0488OC","article-title":"Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease","volume":"180","author":"Dransfield","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1378\/chest.10-0738_bib320","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1086\/606046","article-title":"The immunogenicity of 7-valent pneumococcal conjugate vaccine versus 23-valent polysaccharide vaccine in adults aged 50\u201380 years","volume":"49","author":"Goldblatt","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1378\/chest.10-0738_bib330","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1056\/NEJMoa0903029","article-title":"A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults","volume":"362","author":"French","year":"2010","journal-title":"N Engl J Med"},{"issue":"9221","key":"10.1378\/chest.10-0738_bib340","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(00)02377-1","article-title":"23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial","volume":"355","author":"French","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1378\/chest.10-0738_bib350","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1086\/515346","article-title":"Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination","volume":"178","author":"Granoff","year":"1998","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1378\/chest.10-0738_bib360","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1086\/591629","article-title":"Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia","volume":"198","author":"Musher","year":"2008","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1378\/chest.10-0738_bib370","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1086\/649839","article-title":"Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults","volume":"201","author":"Musher","year":"2010","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1378\/chest.10-0738_bib380","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1086\/651131","article-title":"Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 > or = years","volume":"201","author":"Manoff","year":"2010","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1378\/chest.10-0738_bib390","first-page":"378","article-title":"Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults","volume":"66","author":"Hak","year":"2008","journal-title":"Neth J Med"},{"issue":"11","key":"10.1378\/chest.10-0738_bib410","first-page":"649","article-title":"Factors inhibiting use of the pneumococcal polysaccharide vaccine: a survey of Connecticut physicians","volume":"62","author":"Metersky","year":"1998","journal-title":"Conn Med"},{"issue":"RR\u20136","key":"10.1378\/chest.10-0738_bib430","first-page":"1","article-title":"Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"47","author":"Centers for Disease Control and Prevention","year":"1998","journal-title":"MMWR Recomm Rep"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236921060459X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236921060459X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:21:08Z","timestamp":1757917268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001236921060459X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S001236921060459X"],"URL":"https:\/\/doi.org\/10.1378\/chest.10-0738","relation":{},"ISSN":["0012-3692"],"issn-type":[{"type":"print","value":"0012-3692"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determining the Optimal Pneumococcal Vaccination Strategy for Adults","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.10-0738","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}